Piramal Pharma Appoints Viral Gandhi as Chief Technology Officer
Piramal Pharma Ltd 路 Change in Management 路 01 Oct 2026, 1:38 am
Piramal Pharma Appoints Viral Gandhi as Chief Technology Officer Piramal Pharma Limited鈥檚 Board of Directors approved the appointment of Mr. Viral Gandhi as Chief Technology Officer and Senior Management Personnel, effective 1st Oct'26. Mr. Gandhi currently serves as President and Group CIO at Piramal Group, bringing over 25 years of technology strategy experience. His prior roles include CIO at Cox & Kings Group and leading digital transformation engagements at Tata Consultancy Services (TCS) for Fortune 100 clients. Mr. Gandhi is not related to any Director of the company.
Original exchange filing (PDF)
More announcements from Piramal Pharma Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund 路 31 Oct 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI LODR Regulations, 2015 路 30 Oct 2026
- Please find enclosed details of Earning call Transcript held on 28th October 2026. 路 30 Oct 2026
- Please find enclosed intimation of audio recordings of the conference call held today 28th October, 2026. 路 28 Oct 2026
- Please find enclosed Investor presentation for quarter ended 30 September, 2026 路 28 Oct 2026
- Please find enclosed Press release for quarter ended 30 September, 2026 路 28 Oct 2026
- Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Please find enclosed unaudited financial results for Q2 FY 27 路 28 Oct 2026
